Who Buys Meropenem from India — 966 Importers Behind a $222.9M Market
India's meropenem import market is served by 966 active buyers who collectively imported $222.9M across 3,658 shipments. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with a 31.3% market share, followed by M/S. SUN PHARMA ANZ PTY LTD and EUGIA US LLC,. The top 5 buyers together control 52.1% of total import value, reflecting a moderately competitive buyer landscape.
Top Meropenem Importers — Ranked by Import Value
YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the leading meropenem importer from India, holding a 31.3% share of the $222.9M market across 3,658 shipments from 966 buyers. The top 5 buyers — YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), M/S. SUN PHARMA ANZ PTY LTD (AUSTRALIA), EUGIA US LLC, (UNITED STATES), VENUS PHARMA GMBH (GERMANY), EUGIA US LLC (UNITED STATES) — collectively control 52.1% of total import value.
Top Meropenem Buyers & Importers
Ranked by import value · 966 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM MEROPENEM SUN INJ 1G 10X1V 30ML IT PACKMEROPENEM SUN INJ 1G 10X1V 30ML SE/FI PAMEROPENEM INJ 1GM ( NABLERAN INJ 1000MG | $69.8M | 5 | 31.3% |
| 2 | M/S. SUN PHARMA ANZ PTY LTDAUSTRALIA MEROPENEM RANBAXY 1GM PACK:5 VIALS BATCHMEROPENEM RANBAXY 500 MG PACK:5 VIALS BAMEROFIC 1G INJ | $15.5M | 5 | 7.0% |
| 3 | EUGIA US LLC,UNITED STATES MEROPENEM FOR INJECTION 1 G/VIAL (MEROPEMEROPENEM FOR INJECTION USP 1G/VIAL, 30ML VIALMEROPENEM FOR INJECTION 1 G/VIAL,(MEROPE | $13.8M | 5 | 6.2% |
| 4 | VENUS PHARMA GMBHGERMANY MEROPENEM 1.0 GM POWDER FOR SOLUTION FORMEROPENEM 1.0GM POWDER FOR SOLUTION FORMEROPENEM 500 MG POWDER FOR SOLUTION FOR | $9.3M | 5 | 4.2% |
| 5 | EUGIA US LLCUNITED STATES MEROPENEM FOR INJECTION 1 G/VIAL (MEROPEMEROPENEM FOR INJECTION USP 1G/VIAL, 30ML VIALMEROPENEM FOR INJECTION 1 G/VIAL,(MEROPE | $7.7M | 5 | 3.4% |
| 6 | AUROMEDICS PHARMA, LLC,UNITED STATES | $5.6M | 5 | 2.5% |
| 7 | S T CSAUDI ARABIA MEROPENEM SUN INJ 1G 10X1V 30ML IT PACKMEROPENEM SUN INJ 1G 10X1V 30ML SE/FI PAMEROPENEM RANBAXY 1GM PACK:5 VIALS BATCH | $4.4M | 5 | 2.0% |
| 8 | SALEHIYA TRADING COMPANYSAUDI ARABIA MEROPENEM 1.0 GM POWDER FOR SOLUTION FORMEROPENEM1.0GM PWD FOR SOLUTION FOR INJ. | $3.8M | 5 | 1.7% |
| 9 | E P H KHUNGARY MEROPENEM SUN INJ 1G 10X1V 30ML IT PACKMEROPENEM SUN INJ 1G 10X1V 30ML SE/FI PAMEROPENEM RANBAXY 1GM PACK:5 VIALS BATCH | $3.6M | 5 | 1.6% |
| 10 | INTEGRATED COMMERCIALIZATIONUNITED STATES MEROPENEM FOR INJECTION 1 G/VIAL (MEROPEMEROPENEM FOR INJECTION USP 1G/VIAL, 30ML VIALMEROPENEM FOR INJECTION 1 G/VIAL,(MEROPE | $2.9M | 5 | 1.3% |
| 11 | S T C SALEHIYA TRADINGSAUDI ARABIA MEROPENEM SUN INJ 1G 10X1V 30ML IT PACKMEROPENEM SUN INJ 1G 10X1V 30ML SE/FI PAMEROPENEM RANBAXY 1GM PACK:5 VIALS BATCH | $2.5M | 5 | 1.1% |
| 12 | NATIONS TRUST BANK PLC,SRI LANKA MEROFIC 1G INJMEROFIC 1G MEROPENEM INJECTION 1G (BATCHMEROFIC 1G | $2.2M | 5 | 1.0% |
| 13 | SEYLAN BANK PLC,SRI LANKA MEROFIC 1G INJMEROFIC 1G MEROPENEM INJECTION 1G (BATCHMEROFIC 1G | $2.2M | 5 | 1.0% |
| 14 | VPG VENUS PHARMA GMBHAM BAHNHOFGERMANY MEROPENEM 1.0 GM POWDER FOR SOLUTION FORMEROPENEM 1.0GM POWDER FOR SOLUTION FORMEROPENEM 500 MG POWDER FOR SOLUTION FOR | $2.2M | 5 | 1.0% |
| 15 | COMMERCIAL BANK OF ETHIOPIAETHIOPIA MEROPENEM FOR INJECTION 1 G/VIAL (MEROPEMEROFIC 1G INJMEROPENEM FOR INJECTION USP 1G/VIAL, 30ML VIAL | $2.2M | 5 | 1.0% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Meropenem — and from which countries?
Flow of Meropenem exports from India: each country's share and the named importers behind the numbers
Meropenem — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Belgium
Belgium emerges as the first largest importing country, achieving a total trade value of $71.4M through 143 shipments. This represents a market share of 32.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $69.8M (97.8% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $499.2K, indicating premium pricing strategy compared to the market average of $60.9K.
Belgium is a key market for Meropenem imports, representing 32.0% of total trade value.
2United States
United States emerges as the second largest importing country, achieving a total trade value of $34.6M through 230 shipments. This represents a market share of 15.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EUGIA US LLC, - $13.8M (39.9% of country's total business)
• EUGIA US LLC - $7.7M (22.2% of country's total business)
• AUROMEDICS PHARMA, LLC, - $5.6M (16.2% of country's total business)
• INTEGRATED COMMERCIALIZATION - $2.9M (8.5% of country's total business)
• AUROMEDICS PHARMA, LLC. - $2.0M (5.8% of country's total business)
• Rest of United States's importers - $2.6M (7.5% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $150.2K, indicating premium pricing strategy compared to the market average of $60.9K.
United States is a key market for Meropenem imports, representing 15.5% of total trade value.
3Australia
Australia emerges as the third largest importing country, achieving a total trade value of $19.4M through 7 shipments. This represents a market share of 8.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• M/S. SUN PHARMA ANZ PTY LTD - $15.5M (80.1% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $2.8M, indicating premium pricing strategy compared to the market average of $60.9K.
Australia is a key market for Meropenem imports, representing 8.7% of total trade value.
4Germany
Germany emerges as the fourth largest importing country, achieving a total trade value of $13.3M through 159 shipments. This represents a market share of 6.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• VENUS PHARMA GMBH - $9.3M (69.9% of country's total business)
• VPG VENUS PHARMA GMBHAM BAHNHOF - $2.2M (16.8% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $83.7K, indicating premium pricing strategy compared to the market average of $60.9K.
Germany is a key market for Meropenem imports, representing 6.0% of total trade value.
5Saudi Arabia
Saudi Arabia emerges as the fifth largest importing country, achieving a total trade value of $11.0M through 187 shipments. This represents a market share of 4.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Saudi Arabia has a diverse importer base, with their top importers including:
• S T C - $4.4M (39.8% of country's total business)
• SALEHIYA TRADING COMPANY - $3.8M (34.5% of country's total business)
• S T C SALEHIYA TRADING - $2.5M (22.3% of country's total business)
Key Insight: Saudi Arabia demonstrates strong market positioning with an average shipment value of $58.9K, indicating competitive pricing strategy compared to the market average of $60.9K.
Saudi Arabia is a key market for Meropenem imports, representing 4.9% of total trade value.
Buyer Segment Analysis
TransData Nexus Meropenem buyer market intelligence
1Buyer Segment Analysis
The 966 buyers of Meropenem from India can be categorized into several segments:
1. Distributors: Entities that purchase Meropenem in bulk to supply to various healthcare providers.
2. Contract Manufacturers: Companies that procure Meropenem as an active pharmaceutical ingredient (API) for formulation into finished products.
3. Government Procurement Agencies: Organizations responsible for acquiring medicines for public healthcare systems.
4. Re-exporters: Companies that import Meropenem for the purpose of exporting to other markets.
Each segment exhibits distinct purchasing behaviors. Distributors and contract manufacturers often place large, regular orders to maintain consistent supply chains. Government procurement agencies may engage in bulk purchasing through tender processes, leading to periodic, high-volume orders. Re-exporters' purchasing patterns are influenced by demand fluctuations in their target export markets.
Country-Specific Import Regulations
TransData Nexus Meropenem buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Meropenem are as follows:
1. Belgium
2. United States
3. Australia
4. Germany
5. Saudi Arabia
Demand Drivers & Market Opportunity
TransData Nexus Meropenem buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Meropenem in importing countries is driven by several factors:
1. Disease Prevalence: Meropenem is a broad-spectrum antibiotic used to treat severe infections. High incidences of hospital-acquired infections and antimicrobial resistance have increased its utilization.
2. Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance, leading to increased procurement of effective antibiotics like Meropenem.
3. Universal Health Coverage Expansion: Efforts to expand healthcare access have resulted in higher demand for essential medicines. For instance, Australia's Pharmaceutical Benefits Scheme (PBS) subsidizes essential medicines, enhancing affordability and access.
4. WHO Essential Medicines List Procurement: Meropenem's inclusion in the WHO Model List of Essential Medicines encourages its adoption in national formularies, leading to increased procurement.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender processes to ensure cost-effectiveness and supply security. This approach often results in bulk purchasing of antibiotics like Meropenem.
With 966 buyers across 134 countries, the global market for Meropenem from India is substantial. The combination of disease burden, policy initiatives, and procurement strategies continues to drive demand, presenting significant market opportunities for exporters.
Common Questions — Meropenem Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest meropenem buyer importing from India?
Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $69.8M in imports and a 31.3% market share — the highest of any single meropenem importer. M/S. SUN PHARMA ANZ PTY LTD (AUSTRALIA) and EUGIA US LLC, (UNITED STATES) are the next largest buyers.
QHow many companies buy meropenem from India?
There are 966 active meropenem buyers importing from India, with a combined market of $222.9M across 3,658 shipments to 134 countries. The top 5 buyers hold 52.1% of total import value, while the remaining 961 buyers handle the other 47.9%.
QWhich countries import the most meropenem from India?
The top importing countries for meropenem from India are Belgium (32.0%), United States (15.5%), Australia (8.7%), Germany (6.0%), Saudi Arabia (4.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of meropenem, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for meropenem from India?
The average import transaction value for meropenem from India is $60.9K, with an average unit price of $3.70 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Meropenem buyer market intelligence
1Buyer Segment Analysis
The 966 buyers of Meropenem from India can be categorized into several segments:
1. Distributors: Entities that purchase Meropenem in bulk to supply to various healthcare providers.
2. Contract Manufacturers: Companies that procure Meropenem as an active pharmaceutical ingredient (API) for formulation into finished products.
3. Government Procurement Agencies: Organizations responsible for acquiring medicines for public healthcare systems.
4. Re-exporters: Companies that import Meropenem for the purpose of exporting to other markets.
Each segment exhibits distinct purchasing behaviors. Distributors and contract manufacturers often place large, regular orders to maintain consistent supply chains. Government procurement agencies may engage in bulk purchasing through tender processes, leading to periodic, high-volume orders. Re-exporters' purchasing patterns are influenced by demand fluctuations in their target export markets.
Country-Specific Import Regulations
TransData Nexus Meropenem buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Meropenem are as follows:
1. Belgium
2. United States
3. Australia
4. Germany
5. Saudi Arabia
Demand Drivers & Market Opportunity
TransData Nexus Meropenem buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Meropenem in importing countries is driven by several factors:
1. Disease Prevalence: Meropenem is a broad-spectrum antibiotic used to treat severe infections. High incidences of hospital-acquired infections and antimicrobial resistance have increased its utilization.
2. Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance, leading to increased procurement of effective antibiotics like Meropenem.
3. Universal Health Coverage Expansion: Efforts to expand healthcare access have resulted in higher demand for essential medicines. For instance, Australia's Pharmaceutical Benefits Scheme (PBS) subsidizes essential medicines, enhancing affordability and access.
4. WHO Essential Medicines List Procurement: Meropenem's inclusion in the WHO Model List of Essential Medicines encourages its adoption in national formularies, leading to increased procurement.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender processes to ensure cost-effectiveness and supply security. This approach often results in bulk purchasing of antibiotics like Meropenem.
With 966 buyers across 134 countries, the global market for Meropenem from India is substantial. The combination of disease burden, policy initiatives, and procurement strategies continues to drive demand, presenting significant market opportunities for exporters.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 966 global importers of Meropenem identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,658 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 134 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,658 Verified Shipments
966 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists